Liang S, Kumar A
Curr Infect Dis Rep. 2015; 17(7):493.
PMID: 26031965
PMC: 4581522.
DOI: 10.1007/s11908-015-0493-6.
Kumar A
Virulence. 2013; 5(1):80-97.
PMID: 24184742
PMC: 3916387.
DOI: 10.4161/viru.26913.
Jenkins S, Schuetz A
Mayo Clin Proc. 2012; 87(3):290-308.
PMID: 22386185
PMC: 3496983.
DOI: 10.1016/j.mayocp.2012.01.007.
Olajuyigbe O, Afolayan A
Molecules. 2012; 17(2):2103-18.
PMID: 22354188
PMC: 6268967.
DOI: 10.3390/molecules17022103.
Dugourd D, Yang H, Elliott M, Siu R, Clement J, Straus S
Antimicrob Agents Chemother. 2011; 55(8):3720-8.
PMID: 21576435
PMC: 3147646.
DOI: 10.1128/AAC.00322-11.
Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.
Pfaller M, Sheehan D, Rex J
Clin Microbiol Rev. 2004; 17(2):268-80.
PMID: 15084501
PMC: 387411.
DOI: 10.1128/CMR.17.2.268-280.2004.
Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.
Stratton C
Emerg Infect Dis. 2003; 9(1):10-6.
PMID: 12533275
PMC: 2873758.
DOI: 10.3201/eid0901.020172.
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial species.
Geerdes-Fenge H, Wiedersich A, Wagner S, Lehr K, Koeppe P, Lode H
Antimicrob Agents Chemother. 2000; 44(12):3478-80.
PMID: 11083664
PMC: 90229.
DOI: 10.1128/AAC.44.12.3478-3480.2000.
Clinical pharmacokinetics and pharmacodynamics of isepamicin.
Tod M, Padoin C, Petitjean O
Clin Pharmacokinet. 2000; 38(3):205-23.
PMID: 10749517
DOI: 10.2165/00003088-200038030-00002.
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
Tod M, Lortholary O, Seytre D, Semaoun R, Uzzan B, Guillevin L
Antimicrob Agents Chemother. 1998; 42(4):849-56.
PMID: 9559795
PMC: 105554.
DOI: 10.1128/AAC.42.4.849.
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
Van der Auwera P, Duchateau V, Lambert C, Husson M, Kinzig M, Sorgel F
Antimicrob Agents Chemother. 1993; 37(9):1860-8.
PMID: 8239597
PMC: 188083.
DOI: 10.1128/AAC.37.9.1860.
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
Paulfeuerborn W, Muller H, Borner K, Koeppe P, Lode H
Antimicrob Agents Chemother. 1993; 37(9):1835-41.
PMID: 8239592
PMC: 188078.
DOI: 10.1128/AAC.37.9.1835.
Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Joshi J, Newman K, BROWN B, Finley R, Ruxer R, Moody M
Support Care Cancer. 1993; 1(4):186-94.
PMID: 8193880
DOI: 10.1007/BF00366445.
Infections in cancer patients: some controversial issues.
Schimpff S, Scott D, Wade J
Support Care Cancer. 1994; 2(2):94-104.
PMID: 8156272
DOI: 10.1007/BF00572090.
Gram-negative bacteremia.
Schimpff S
Support Care Cancer. 1993; 1(1):5-18.
PMID: 8143100
DOI: 10.1007/BF00326634.
Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.
Dan M, Poch F, Quassem C, Kitzes R
Antimicrob Agents Chemother. 1994; 38(4):837-41.
PMID: 8031055
PMC: 284551.
DOI: 10.1128/AAC.38.4.837.
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
Piccart M, Klastersky J, Meunier F, Lagast H, Van Laethem Y, Weerts D
Antimicrob Agents Chemother. 1984; 26(6):870-5.
PMID: 6524903
PMC: 180041.
DOI: 10.1128/AAC.26.6.870.
Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
Barriere S, Ozasa D, Mordenti J
Antimicrob Agents Chemother. 1985; 28(1):55-7.
PMID: 3929680
PMC: 176309.
DOI: 10.1128/AAC.28.1.55.
Nosocomial pneumonia in patients in intensive care units.
Podnos S, Toews G, Pierce A
West J Med. 1985; 143(5):622-7.
PMID: 3909641
PMC: 1306425.
BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteers.
Van der Auwera P, Lieppe S, Klastersky J
Antimicrob Agents Chemother. 1986; 29(5):757-9.
PMID: 3755314
PMC: 284149.
DOI: 10.1128/AAC.29.5.757.